HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors | MicrobiomeTrials← Back to trialsNCT03911388
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2019-09-12Est. Completion: 2026-09-01
Enrollment target: 24 participants Locations- University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
- Siteman Cancer Center at Washington University, St Louis, Missouri, United States
- MD Anderson Cancer Center, Houston, Texas, United States
Other microbiome trials you might be interested in
Rare DiseasesGeneralized Myasthenia Gravis (gMG)
This is a multicenter, non-interventional, retrospective-prospective, single-arm observational study designed to describ…
Kazan', RussiaEst. completion Dec 31, 2029
Malignant Glioma
This phase I/II trial tests the safety, side effects, and best dose of selinexor given in combination with standard radi…
Birmingham, United StatesEst. completion Jun 30, 2027
Recruiting
Childhood Hematopoietic and Lymphatic System NeoplasmChildhood Malignant Solid Neoplasm
This clinical trial tests the feasibility and acceptability of the Strengthening Teen Brain Resilience Using Music (STRU…
Scottsdale, United StatesEst. completion Nov 1, 2028